Detailed View
INDV - Indivior Pharmaceuticals, Inc.
Latest filing: 2026-09-30 | Reporting: gaap
Market Cap
4,282,319,616
Adj EBIT (TTM)
591,000,000
Enterprise Value
4,465,319,616
Last Price
36.28
Earnings Yield
13.24%
Return on Capital
2037.93%
Capital
29,000,000
1Y Price Chart
Last Price: $36.28
1Y Change: 24.55%
As of 2026-11-02 | 1Y Change: 24.55%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-09-30 | 10-Q | 2026 | 356,000,000 | 180,000,000 |
| 2026-06-30 | 10-Q | 2026 | 343,000,000 | 160,000,000 |
| 2026-03-31 | 10-Q | 2026 | 317,000,000 | 137,000,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 357,000,000 | 81,000,000 |
| 2025-09-30 | 10-Q | 2025 | 314,000,000 | 43,000,000 |
| 2025-06-30 | 10-Q | 2025 | 302,000,000 | 72,000,000 |
| 2025-03-31 | 10-Q | 2025 | 266,000,000 | 66,000,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.